Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.

HCoV SARS-CoV-2 children cross-immunity pre-exisiting immunity respiratory infection

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
25 Jan 2024
Historique:
medline: 25 1 2024
pubmed: 25 1 2024
entrez: 25 1 2024
Statut: aheadofprint

Résumé

Numerous clinical parameters link to severe coronavirus disease 2019, but factors that prevent symptomatic disease remain unknown. We investigated the impact of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and endemic human coronavirus (HCoV) antibody responses on symptoms in a longitudinal children cohort (

Identifiants

pubmed: 38270455
doi: 10.1128/mbio.02722-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0272223

Auteurs

Irene A Abela (IA)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Magdalena Schwarzmüller (M)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Agne Ulyte (A)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Thomas Radtke (T)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Sarah R Haile (SR)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Priska Ammann (P)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Alessia Raineri (A)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Sonja Rueegg (S)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Selina Epp (S)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Christoph Berger (C)

University Children Hospital Zurich, Zurich, Switzerland.

Jürg Böni (J)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Amapola Manrique (A)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Annette Audigé (A)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Michael Huber (M)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Peter W Schreiber (PW)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Thomas Scheier (T)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Jan Fehr (J)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Jacqueline Weber (J)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Peter Rusert (P)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Huldrych F Günthard (HF)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Roger D Kouyos (RD)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Milo A Puhan (MA)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Susi Kriemler (S)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.

Alexandra Trkola (A)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Chloé Pasin (C)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Collegium Helveticum, Zurich, Switzerland.

Classifications MeSH